Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Hydrocyanation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN1743308A reveals an enzymatic asymmetric synthesis route for thiamphenicol and florfenicol intermediates, offering significant cost reduction and supply chain reliability for veterinary pharmaceutical manufacturing.
Patent CN1076342C reveals advanced multidentate phosphite ligands for high-yield adiponitrile production, offering cost reduction and supply chain reliability.
Novel hydrocyanation process using nickel catalyst enhances purity and yield for nitrile compounds, offering cost-effective supply chain solutions for global pharmaceutical manufacturers.
Patent CN102177166A reveals a catalytic route for halogen-free flame retardants. Discover cost-effective manufacturing and high-purity supply chain solutions.
Patent CN102190640B reveals a cost-effective HCN-based synthesis for azoxystrobin intermediates, offering high yields and reduced waste for reliable agrochemical supply chains.
Patent CN1314880A details a novel enantioselective hydrocyanation method for producing high-purity optically active alpha-aminonitriles, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN1144781C details a novel hydrocyanation method for C5 mononitriles using selective hydrogenation, offering significant cost reduction and improved catalyst recovery for industrial scale-up.
Patent CN1169143A details a novel liquid-phase hydrocyanation method using multidentate phosphite ligands, offering significant cost reduction in nylon precursor manufacturing and enhanced supply chain reliability.
Novel two-step synthesis from styrene reduces cost and improves purity for pharmaceutical manufacturing supply chains.
Patent CN1293942C reveals a robust Ni(0) catalyst system using metallic nickel powder for efficient adiponitrile synthesis, offering significant cost and stability advantages.
Patent CN110845364B details a green Ni-catalyzed method using formamide. Offers cost-effective, scalable routes for pharmaceutical intermediates.